Home » Topics » Regulatory » Patents

Patents
RSS

Merck & Co. discloses novel antifungal agents

Jan. 14, 1997

Thomae reports agents for hypercholesterolemia

Jan. 14, 1997

New compounds for heparin reversal disclosed by University of Michigan

Jan. 14, 1997

NO donors claimed by Searle for cardiovascular applications

Jan. 13, 1997

Allergan claims retinoid-like compounds

Jan. 13, 1997

Dual TNF/PDE IV inhibitors described by Chiroscience

Jan. 13, 1997

New topoisomerase I inhibitors synthesized at Rutgers

Jan. 13, 1997

New approach to obesity gene research at Lilly

Jan. 13, 1997

French researcher discloses preventive effects of tryptamine derivatives

Jan. 13, 1997

Merck Frosst discloses leukotriene biosynthesis inhibitors

Jan. 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...